Acute Respiratory Distress Syndrome Analysis Report 2024: A $2.36 Billion Market by 2032 from $1.23 Billion in 2023
18 juil. 2024 06h27 HE
|
Research and Markets
Dublin, July 18, 2024 (GLOBE NEWSWIRE) -- The "Acute Respiratory Distress Syndrome Market Report by Type, End User, Regions and Company Analysis 2024-2032" report has been added to ...
RS BioTherapeutics Announces Research Collaboration with University of Colorado School of Medicine
08 juil. 2024 10h00 HE
|
RS BioTherapeutics
CUMBERLAND, Md., July 08, 2024 (GLOBE NEWSWIRE) -- RS BioTherapeutics, whose mission is to develop life-changing medicines for the millions of people suffering from deadly lung diseases...
Study Estimates a 23% Increase in COPD by 2050, Representing 600 Million Patients Globally
07 déc. 2023 15h34 HE
|
ResMed Inc.
New study shows Chronic Obstructive Pulmonary Disease (COPD) increasing globally through 2050, with 47% growth among women.
APIE Therapeutics Welcomes Jim Greenwood to its Board of Directors
21 mars 2023 08h00 HE
|
APIE Therapeutics
Cary, NC, March 21, 2023 (GLOBE NEWSWIRE) -- APIE Therapeutics (APIE Tx), a preclinical pharmaceutical company pioneering novel and proprietary drugs to activate the apelin receptor (APJ), announced...
DirectRx Specialty Pharmacy Pledges Support to the COPD Foundation as a Corporate Social Responsibility Partner
16 mars 2023 12h06 HE
|
DirectRx Pharmacy
TROY, Mich., March 16, 2023 (GLOBE NEWSWIRE) -- DirectRx, a leading national specialty pharmacy dedicated to serving individual patients with complex and chronic health needs, today announced it has...
Interstitial Lung Disease Clinical Trial Pipeline Insights | DelveInsight
22 juin 2022 12h00 HE
|
DelveInsight Business Research LLP
Las Vegas, USA, June 22, 2022 (GLOBE NEWSWIRE) -- Interstitial Lung Disease Clinical Trial Pipeline Insights | DelveInsight Interstitial lung disease Pipeline involves 120+ key companies...
Angion Announces Phase 1b Trial of ANG-3070 in Patients with Idiopathic Pulmonary Fibrosis
16 mai 2022 00h05 HE
|
Angion Biomedica Corp.
-- The FDA has accepted an IND application supporting clinical development of ANG-3070 in IPF -- Phase 1b trial to be initiated to gather tolerability, safety, and pharmacokinetic data in IPF...
The First PHantasticals Come to Life to Raise Awareness of Pulmonary Hypertension
05 mai 2022 05h00 HE
|
Ferrer
BARCELONA, Spain, May 05, 2022 (GLOBE NEWSWIRE) -- Coinciding with World Pulmonary Hypertension (PH) Day, which is celebrated every May 5, Ferrer and the European Pulmonary Hypertension Association...
Asthma Drugs Market Size Worth $34.13Bn, Globally, by 2028 at 5% CAGR - Exclusive Report by The Insight Partners
04 mai 2022 06h10 HE
|
The Insight Partners
New York, May 04, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Asthma Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Medications (Quick...
APIE Therapeutics Augments Leadership Team with Addition of Chief Business Officer and Chief Medical Officer
12 janv. 2022 07h30 HE
|
APIE Therapeutics
Cary, NC, Jan. 12, 2022 (GLOBE NEWSWIRE) -- APIE Therapeutics, a preclinical biopharma company pioneering microvasculature endothelium drug development by targeting the apelin receptor (APJ),...